Written Question·Department of Health and Social Care·UIN 73126
Obesity: Drugs
Tabled: 29 August 2025
Answered: 9 September 2025
Question
Mr Andrew Snowden
Conservative — Fylde
To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure post-market surveillance of NHS-provided weight loss drugs to monitor their long-term effects in patients.
Answer
Ashley DaltonThe newest obesity medicines, liraglutide, under various brand names, semaglutide, under the brand name Wegovy, and tirzepatide, under the brand name Mounjaro, have only been licensed and recommended for use for the treatment of obesity over the last few ...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 73126) →